La Trobe University

Bachelor of Biomedicine

La Trobe University

Type of institution: University/Higher Education Institution
Level: Undergraduate
CRICOS: 00115M

There's never been a better time to build new skills and follow your passion. Apply now to secure your place at La Trobe. Start in 2023 and you could get a STEM industry placement bursary of $2,500 when you complete a Work-Based Learning subject as part of your studies at La Trobe. Discover exciting careers in biomedicine and biotechnology – or build the foundations for further study in medicine, dentistry or allied health. From day one, learn from experts and get hands-on experience in the lab with La Trobe's Bachelor of Biomedicine.


To qualify for the award of Bachelor of Biomedicine, students must complete a total of 360 credit points across 3 years.


  • First Year Subjects: Academic Integrity Module
  • Applications of Chemistry
  • Chemistry Foundations
  • Foundations of Biomedical Science
  • Human Biosciences B
  • Human Structure and Function
  • Infections, Pandemics and Epidemics
  • Molecules, Genes and Cells
  • Wominjeka La Trobe: Indigenous Cultural Literacy for Higher Education

Standard entry requirements

Recent secondary education (within the last two years). VCE: Units 3 and 4: a study score of at least 25 in English (EAL) or at least 20 in English other than EAL.

Study information

CampusFeesMid year intakeAttendance
Melbourne (Bundoora) International: $115,800 Yes
  • Full-time : 3 years

Fee comments

Campuses: Melbourne (Bundoora).

Your course fees will depend on the subjects you choose to study: each subject has its own costs. The total course fee may vary depending on the subjects you choose, your study load, the time it takes to complete your course and your approved Credit for Prior Learning. Fees correct Tuesday, Feb 28 2023

Related courses

Browse more courses
Is the information on this page correct? Request update
Enquire about this course

Are you currently in Australia?

You must agree before submitting.

Subscribe to our newsletter

Join the conversation